Beijing: An HIV vaccine being developed by Chinese scientists will be given to 160 volunteers in a second-phase clinical trial, a scientist at the Chinese Center for Disease Control and Prevention said.
The candidate vaccine, DNA-rTV, relies on replication of the DNA of HIV to stimulate effective immunisation, according to Shao Yiming, a chief HIV researcher at the centre.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
